- Home
- Specialized Research
Specialized Research
Research Compounds Advanced Laboratory Compounds
This category includes GHK-Cu (glycyl-histidyl-lysine copper tripeptide, a widely studied copper research compound), AHK-Cu (alanyl-histidyl-lysine copper tripeptide, a structurally distinct copper compound variant), Kisspeptin-10 (a GPR54 receptor agonist for hypothalamic-pituitary-gonadal axis research), Thymosin Alpha-1 (a thymic peptide with the most extensive clinical immune research of any compound on this site), and Melanotan I (a selective MC1R agonist for melanocyte and pigmentation pathway research).
All five compounds are independently third-party tested to greater than 99% purity with batch-specific Certificate of Analysis documentation. Each represents a specialized research tool for scientists working in tissue remodeling, endocrine axis biology, immune signaling, or melanocyte pathway research.
Copper Compounds in Research — GHK-Cu & AHK-Cu
Copper peptides are small peptide-copper complexes that act as copper transport and signal molecules in biological systems. Copper is an essential trace element and cofactor for numerous enzymes involved in connective tissue synthesis, antioxidant defense, and cellular signaling. Copper peptide research has expanded significantly over the past decade as genomic analysis tools have revealed the breadth of gene expression modulation these small complexes can induce.
GHK-Cu (glycyl-histidyl-lysine) and AHK-Cu (alanyl-histidyl-lysine) represent two distinct copper peptide tripeptides with different amino acid compositions and partially different biological research profiles. GHK-Cu is by far the more extensively studied of the two — with over five decades of published research and genomic analyses showing modulation of more than 4,000 human genes. AHK-Cu is a newer research compound with a distinct structural profile being investigated for its copper transport and cellular signaling differences versus GHK-Cu.
GHK-Cu — Widely Studied Copper Compound in Research
GHK-Cu (Copper Tripeptide-1) — 50mg | 100mg
Glycyl-Histidyl-Lysine Copper Complex — Gene Expression Research
GHK-Cu (Glycine-Histidine-Lysine bound to copper(II)) is a naturally occurring tripeptide-copper complex first identified in plasma in 1973 by researcher Loren Pickart. It is one of the most extensively studied peptides in biomedical literature, with research spanning wound healing, dermatology, neurology, hair biology, and gene expression profiling over five decades. Natural plasma levels of GHK-Cu decline approximately 60% between early adulthood and age 60 — underlying much of the longevity research interest in this compound.
The most distinctive research finding on GHK-Cu comes from a Broad Institute Connectivity Map analysis: at nanomolar concentrations, GHK modulates the expression of approximately 4,192 genes — roughly one-third of the assayed human genome. The direction of modulation is notable: genes associated with DNA repair, antioxidant response, tissue remodeling, and anti-inflammatory signaling are predominantly upregulated, while genes associated with cancer progression and inflammatory processes are predominantly downregulated. This broad gene expression profile has made GHK-Cu one of the most data-rich compounds in research literature.
In tissue and cellular research, GHK-Cu is studied for fibroblast activation and proliferation, collagen and elastin synthesis upregulation, matrix metalloproteinase (MMP) modulation for scar remodeling, antioxidant enzyme upregulation (superoxide dismutase, catalase), hair follicle research and dermal papilla signaling, and wound healing angiogenesis. GHK-Cu is available in two sizes — 50mg and 100mg — both available on the same product page via dropdown selection.
Key Research Areas:
- Gene expression modulation (4,000+ genes)
- Fibroblast activation
- Collagen/elastin synthesis
- MMP-mediated tissue remodeling
- Antioxidant signaling
- Hair follicle biology
Available:
- GHK-Cu 50mg and GHK-Cu 100mg
AHK-Cu — Alanyl Histidyl Lysine Copper Compound
AHK-Cu — 100mg
Alanyl-Histidyl-Lysine Copper Complex — Copper Peptide Research
AHK-Cu (Alanine-Histidine-Lysine bound to copper(II)) is a copper tripeptide in the same chemical class as GHK-Cu but with a different N-terminal amino acid — alanine replaces glycine in the first position. This single amino acid substitution produces a structurally distinct copper peptide with a partially different biological research profile. AHK-Cu has emerged as a research compound of interest for scientists investigating copper peptide structure-activity relationships — specifically how N-terminal amino acid composition affects copper binding affinity, receptor interactions, and downstream gene expression modulation compared to GHK-Cu.
Research with AHK-Cu examines its copper transport characteristics, cellular uptake patterns, and gene expression profile differences versus GHK-Cu. Hair follicle research has been an area of particular interest, with studies investigating whether the structural difference produces differential effects on dermal papilla signaling and follicle cycling. For researchers conducting comparative copper peptide studies, AHK-Cu and GHK-Cu together provide a controlled structural comparison tool — one variable change (Gly vs Ala at position 1) with otherwise identical peptide backbones.
Key Research Areas:
- Copper peptide structure-activity research
- Comparative studies vs GHK-Cu
- Hair follicle and dermal papilla signaling
- Copper transport and cellular uptake pathway studies
Available:
- AHK-Cu 100mg
Kisspeptin-10 — GPR54 Receptor Signaling Research
Kisspeptin-10 (Metastin-10) — 10mg
Decapeptide — KISS1 Gene Product — GPR54 Agonist
Kisspeptin-10 is a 10-amino acid decapeptide derived from the KISS1 gene — the shortest biologically active fragment of kisspeptin that retains full efficacy at the GPR54 receptor (also known as KISS1R). It was originally identified as a metastasis-suppressor gene product (hence the original name “metastin”) before its central role in endocrine signaling research was discovered. Kisspeptin-10 is selected for research over longer kisspeptin isoforms (kisspeptin-54, kisspeptin-13) because of its improved blood-brain barrier penetration and equivalent GPR54 agonist efficacy.
In laboratory research, Kisspeptin-10 is primarily studied as a pharmacological tool for investigating hypothalamic-pituitary-gonadal (HPG) axis function. GPR54 receptors are expressed on GnRH (gonadotropin-releasing hormone) neurons in the hypothalamus, and kisspeptin-mediated GPR54 activation is studied for its effects on downstream endocrine signaling pathways. Research has demonstrated dose-dependent increases in LH and FSH following Kisspeptin-10 administration in rodent, primate, and human research models.
Beyond reproductive axis research, Kisspeptin-10 research has examined cardiovascular signaling (vasodilatory effects), pancreatic insulin secretion interactions, and metabolic regulatory pathways. Its role as the central activator of the reproductive hormone axis makes it an essential research tool for endocrine biology, fertility pathway research, and HPG axis dysfunction models.
Key Research Areas:
- GPR54 receptor agonism
- GPR54 receptor signaling research
- Endocrine signaling pathway models
- Cardiovascular signaling
- Metabolic endocrine interaction research
Available:
- Kisspeptin-10 10mg
Thymosin Alpha-1 — Immune Signaling & Thymic Peptide Research
Thymosin Alpha-1 (Ta1) — 10mg
28-Amino Acid Thymic Peptide — Immune Modulator
Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide originally isolated from thymic tissue by Allan Goldstein and colleagues in the 1970s. It is one of the most extensively studied immune-signaling research compounds, with a substantial published research literature. Of all compounds on the Midnight Sun Peptides site, Thymosin Alpha-1 has the strongest and most extensive clinical evidence base in peer-reviewed literature, with multiple randomized controlled trials.
In laboratory and clinical research, Thymosin Alpha-1 is studied for its role in T-cell maturation and differentiation signaling, natural killer (NK) cell activation, dendritic cell function modulation, cytokine production regulation (particularly IFN-α, IFN-γ, and IL-2), and toll-like receptor (TLR) pathway modulation. Research has shown Tα1 upregulates key immune signaling molecules while simultaneously modulating inflammatory cytokine production — a balance that has driven interest in both infectious disease and oncology research.
Research applications include immune signaling, inflammatory pathway modulation, and immunological research models. Research applications span immune reconstitution models, antiviral pathway signaling, tumor microenvironment immunology research, and age-related immune decline (immunosenescence) studies.
Key Research Areas:
- T-cell maturation and differentiation
- NK cell activation research
- TLR pathway modulation
- Cytokine signaling (IFN-α, IFN-γ, IL-2)
- Immune aging pathway research
- Antiviral immune research
Available:
- Thymosin Alpha-1 10mg
Melanotan I — Selective MC1R Melanocyte Research Compound
Melanotan I (MT-1, Afamelanotide)
Selective MC1R Melanocortin Agonist — Pigmentation Research
Melanotan I (also known as afamelanotide or MT-1) is a synthetic analog of alpha-melanocyte stimulating hormone (α-MSH). It is a selective agonist for the melanocortin-1 receptor (MC1R) — the primary receptor controlling melanogenesis and skin pigmentation responses. Melanotan I was developed specifically for its MC1R selectivity — it produces strong melanocyte stimulation and photoprotective pigmentation responses without significant activity at MC3R, MC4R, or MC5R, supporting its selective MC1R research profile.
This receptor selectivity profile is the defining research characteristic that distinguishes Melanotan I from Melanotan II. Melanotan II (not carried by Midnight Sun Peptides) is a non-selective melanocortin agonist with has broader melanocortin receptor activity, including MC4R, making it mechanistically distinct from the selective MC1R profile of Melanotan I. Melanotan I’s selective MC1R profile makes it a more targeted research tool for melanogenesis pathway research, MITF (Microphthalmia-associated Transcription Factor) activation studies, and photoprotection research models.
Afamelanotide is a pharmacologically characterized MC1R agonist used in research investigating melanocortin receptor signaling, melanogenesis pathways, and photoprotection mechanisms.
Important: Melanotan I (MT-1) is NOT the same as Melanotan II (MT-2). Melanotan II has broad melanocortin receptor activity including MC4R (sexual function). Melanotan I has a selective MC1R profile and is studied for melanogenesis, melanocyte signaling, and related receptor research.
Key Research Areas:
- Selective MC1R agonism
- Melanogenesis and MITF pathway research
- Photoprotection signaling models
- Melanocyte receptor pharmacology
- EMA-approved mechanism (Scenesse/EPP)
Available:
- Melanotan I
Why Purity & Documentation Matter in Specialized Research
Specialized research compounds require especially rigorous purity verification. Copper peptide research involves nanomolar concentration studies where trace impurities can significantly alter gene expression results. Immune research with Thymosin Alpha-1 requires precise compound identity — particularly given the existence of related thymosin peptides (Thymosin Beta-4, Thymosin Alpha-11) that could be confused with Tα1. Melanocortin research requires clear compound identity to distinguish MC1R-selective compounds (Melanotan I) from non-selective ones (Melanotan II).
Every specialized research compound sold by Midnight Sun Peptides undergoes independent third-party testing including:
- HPLC Purity Analysis — confirms exact purity percentage, critical for nanomolar concentration copper peptide research
- Mass Spectrometry Identity Confirmation — verifies molecular weight and compound identity, essential for distinguishing between closely related peptides
- Batch-Specific COA — actual test report for your production lot, enabling complete compound traceability in research records
Frequently Asked Questions
What is the difference between GHK-Cu and AHK-Cu?
GHK-Cu is glycyl-histidyl-lysine copper complex — the N-terminal amino acid is glycine. AHK-Cu is alanyl-histidyl-lysine copper complex — the N-terminal amino acid is alanine instead of glycine. This single amino acid substitution at position 1 produces two structurally distinct copper peptide complexes with partially different biological research profiles. GHK-Cu has over five decades of published research including genomic analyses showing modulation of 4,000+ human genes. AHK-Cu is a newer research compound studied for how its structural difference produces distinct copper transport characteristics and receptor interactions — making it a useful paired research tool for copper peptide structure-activity studies alongside GHK-Cu.
What is Kisspeptin-10 and why is it used in research?
Kisspeptin-10 is a 10-amino acid decapeptide derived from the KISS1 gene and the endogenous ligand for the GPR54 receptor (KISS1R). It is the shortest bioactive kisspeptin fragment that retains full GPR54 agonist efficacy — making it preferable for research over longer isoforms (kisspeptin-54, -13) due to improved blood-brain barrier penetration. In laboratory research, it is used as a pharmacological tool for investigating the hypothalamic-pituitary-gonadal (HPG) axis — GPR54 activation on hypothalamic GnRH neurons triggers the master hormone cascade for reproductive function (GnRH → LH → FSH → sex hormones). It is also studied for cardiovascular signaling and metabolic endocrine pathway interactions.
What is Thymosin Alpha-1 and how does it differ from Thymosin Beta-4 (TB-500)?
Thymosin Alpha-1 (Tα1) and Thymosin Beta-4 (the source compound for TB-500) are two completely different thymosin family peptides with entirely different biological activities. Thymosin Alpha-1 is a 28-amino acid thymic peptide that modulates immune function — specifically T-cell maturation, NK cell activation, and cytokine signaling. It is approved as Zadaxin in 35+ countries for immune indications. Thymosin Beta-4 (TB-500) is a 43-amino acid actin-binding peptide involved in cell migration and tissue repair — not immune function. They share the “thymosin” family name but have different sequences, different mechanisms, and entirely different research applications. TB-500 is in our Recovery category; Thymosin Alpha-1 is in Specialized Research.
What is the difference between Melanotan I and Melanotan II?
Melanotan I (MT-1, afamelanotide) is a selective MC1R agonist — it targets only the melanocortin-1 receptor, which controls melanogenesis and skin pigmentation. Melanotan I does not have significant activity at MC4R. Melanotan II (MT-2) is a non-selective melanocortin agonist with activity at MC3R, MC4R, and MC5R in addition to MC1R — the MC4R activity produces the sexual arousal responses that Melanotan II is often associated with. Midnight Sun Peptides carries Melanotan I only. We do not carry Melanotan II. Melanotan I research focuses strictly on melanocyte biology, MITF pathway activation, and photoprotection signaling — not sexual function research.
What purity level are these specialized research compounds?
All specialized research peptides are independently third-party tested at greater than 99% purity using HPLC analysis and mass spectrometry identity confirmation. For specialized compounds like GHK-Cu and Thymosin Alpha-1 — where structural identity is critical and closely related compounds exist — mass spectrometry identity confirmation is especially important. Batch-specific Certificates of Analysis are available on every product page, showing the actual test results for your specific production lot.
Research Use Only Disclaimer:
All products on this page are sold strictly for laboratory and controlled scientific research purposes only. These compounds are not approved by the FDA or any regulatory authority for human or veterinary use. They are not intended for consumption, therapeutic application, or administration to humans or animals. All use must remain within qualified laboratory research settings.
